Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-13004035Phase 4Completed
Phase 4, open-label trial of sevoflurane and propofol in coronary arteriosclerosis (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoints: microRNA-499 and microRNA-208b. Started Jan 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-13004035.